Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Medicare can now cover certain weight loss drugs in a big step for patients
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Healthy Returns: The first drug for a common, deadly liver disease is here – and more are coming
Tags Novo Nordisk A/S Science Zealand Pharma A/S
From CNBC.com News
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Biotechnology Business News CVS Health Corp
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Biotechnology Business News Madrigal Pharmaceuticals Inc
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Drugs Health care industry Pharmaceuticals
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags ETF Edge Investing U/S/ Markets
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Health care industry Companies Pharmaceuticals
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Stock markets Markets U/S/ Markets
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Novo Nordisk A/S Business News Social issues
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Biotech and Pharmaceuticals US: News Business News
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Breaking News: Markets Pharmaceuticals Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags Eli Lilly and Co Health & Science Novo Nordisk A/S
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Eli Lilly and Co Business Health & Science
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags NVIDIA Corp Business News Stock markets
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Health & Science Business Eli Lilly and Co
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Europe Politics UBS Group AG UniCredit SpA
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Paramount Global Salesforce Inc Economy
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Europe Markets Prices Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Paramount Global Alphabet Inc Eli Lilly and Co
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Herbalife Ltd Diets and dieting Weight loss diets
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Novo Nordisk A/S Drug trials Animal health
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Health care industry UnitedHealth Group Inc Eli Lilly and Co
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Investment strategy Novo Nordisk A/S Roche Holding AG
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Europe News Zealand Pharma A/S Pharmaceuticals
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Eli Lilly and Co Health & Science Social issues
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Health care industry Pharmaceuticals Companies
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags US: News Biotechnology Business News
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Biotechnology Business News US: News
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Markets Investing Health care industry
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Bristol/Myers Squibb Co Johnson & Johnson Pfizer Inc
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.